Global Institute Of Stem Cell Therapy And Research
US: +1-800-914-7836

Archives

Author's Posts

Stem Cell Revolution Trudges Forward

Stem Cell Revolution Trudges Forward

We are still in the early stages [of stem cell treatment]. In 2014, Dr. Masayo Takahashi and her colleagues at the Riken Center for Developmental Biology had great success using iPS cells to treat macular degeneration.

In some ways, yes, [the promise of stem cells] is overstated. For example, target diseases for cell therapy are limited. There are about 10: Parkinson’s, retinal and corneal diseases, heart and liver failure, diabetes and only a few more — spinal cord injury, joint disorders and some blood disorders…The number of human diseases is enormous.

Stem Cell Revolution Trudges Forward

I think the science has moved too far ahead of talk of ethical issues. When we succeeded in making iPS cells, we thought, wow, we can now overcome ethical issues of using embryos to make stem cell lines.

But soon after, we realized we are making new ethical issues. We can make a human kidney or human pancreas in pigs if human iPS cells are injected into the embryo. But how much can we do those things?

It is very controversial. These treatments may help thousands of people. So getting an ethical consensus is extremely important.

Source : https://goo.gl/1tIykZ

Dr. Anand’s Invitation from Journal of Integrative Molecular Medicine to Submit and Article to Enhance Journal Rating

Dr. Anand’s Invitation from Journal of Integrative Molecular Medicine to Submit and Article to Enhance Journal Rating

Dear Doctor Srivastava,

Hope you are doing well.

Integrative Molecular Medicine (IMM) welcomes you to contribute any type of articles for Volume 4 Issue 1. Kindly submit your article by January 20th, 2017. Your scientific contribution would help in enhancing the rating of this journal.

Our journal is indexed in the following services mentioned below:

Google Scholar, German Cancer Research Center, EZB Electronic Journals Library, World cat, Zeitschriftendatenbank (ZDB), Citefactor, Road Directory, SciCurve, AS-FHJ, RefSeek. We are applied for Indexing in EBSCO, EMBASE, and CAS. We are sure that your article will enhance the impact of our journal.

https://oatext.com/IntegrativeMolecularMedicine.php#External_Databases_Indexes

Awaiting your response.

Feel free to contact us for further queries.

Best regards,

Ian White

Managing Editor for Editor-in-chief (Koji Wakame)

Integrative Molecular Medicine (IMM) (2056-6360)

Invitation to join the Editorial Board of AIMS Cell and Tissue Engineering

Invitation to join the Editorial Board of AIMS Cell and Tissue Engineering

Dear Prof. Srivastava,

Please excuse us for sending this invitation again. We would appreciate if you can give us a reply soon.
Many thanks for your cooperation.

On behalf of AIMS Press and given your high reputation and significant contributions in cell/tissue engineering area,
We would like to invite you to join the Editorial Board of AIMS Cell and Tissue

Engineering (http://www.aimspress.com/journal/CTE ).

As a new journal launched by AIMS Press, AIMS Cell and Tissue Engineering is an international Open Access journaldevoted to publishing
peer-reviewed, high quality, original papers in the field of cell and tissue engineering.
All fees of publishing are fully waived for the initial three years for AIMS Cell and Tissue Engineering.
About AIMS Press Since 1995, AIMS Press (http://www.aimspress.com) has published 5 of the flagship journals in SCI
and others in SCI-E. We never lose sight of the status and functions of editorial board value, without their
pivot roles, it is impossible to imagine our journal becoming high-

Impact from conception to completion.Terms and responsibilities of Editorial Board members:

1. Each editorial board member will serve a 3 year term, which is renewable. Toward the end of each term,
a member may express his/her desire to stay on the board or retire. The Editor in Chief and journal manager
may review the member’s performance from the last 3 years and decide if renewal of their term is suitable.
2. An editorial board member may be asked to review up to 3 papers related to his/her research interests each year.
3. An editorial board member is expected to contribute a paper to the journal during his/her 3-year term.
4. An editorial board member is expected to guest-edit a special issue on topics of his/her choice during his/her 3-year term.

Honorarium of the Editorial Board members:

1. Editorial board members can publish papers free of charge in AIMS Press journals.
2. Researchers in the same research group as an editorial board member are granted a 20% discount on the
article processing charge when they publish with AIMS Press journals.
3. Retired editorial board members are granted a 50% discount to publish with AIMS Press journals.

If you accept this invitation, please give us a short reply and a latest CV.

Our editorial board will evaluate your resume and make a final confirmation.
With your input, it will not only be a pivot, but a confluence of pivots of creative ideas.I am looking forward to your reply soon.
* If you do not want to receive this kind of letter, please reply “unsubscribe”.

With regards,
Dr. Yu Min

Managing Editor
AIMS Cell and Tissue Engineering
http://www.aimspress.com/journal/CTE
Email: cell.tissue@aimspress.comOn behalf of Dr. Shouchuan Hu
Professor of Missouri State University
901 S. National, Springfield, MO 65897, USA
Tel & Fax: (417) 889-0336
Director of AIMS Press
Email: editor@aimspress.com
Website: http://www.aimspress.com

Invitation to Speak at The 7th Annual World Congress of Molecular & Cell Biology in China

Invitation to Speak at The 7th Annual World Congress of Molecular & Cell Biology in China

Date: April 25-27, 2017 | Place: Xi’an, China

 

Dear Dr. Anand S Srivastava,

This is Judy writing to wish you and yours a Happy New Year.

The CMCB Organizing Committee is delighted to welcome you to present a speech in Section 410: Tissue Repair & Regeneration. Your prompt reply with a speech proposal will be highly appreciated. Your presence will make conference successful.

CMCB-2017 supporting by Shaanxi Society of Cell Biology is highlighted as Keynote Forum, 36 Parallel Sessions with 300+ Oral Speeches, Posters and Papers, and Diversified Social Events. Each day will include 10 concurrent focus sessions, each focus session featuring speakers who will present cutting-edge research on a wide range of topics. We sincerely welcome you to submit presentation abstract, short paper or preliminary speech title. Please visit the conference website to see the conference details.

If you have any question about the conference, please feel free to let me know.

Kind regards

Judy

The 7th Annual World Congress of Molecular & Cell Biology, Xi’an, China

Dr. Anand Invited to Speak at The 7th Annual World Congress of Molecular & Cell Biology, Xi’an, China

 

The 7th Annual World Congress of Molecular & Cell Biology (CMCB-2017)
Date: April 25-27, 2017 | Place: Xi’an, China

Dear Dr. Anand S Srivastava,

This is Judy writing to wish you and yours a Happy New Year.

The CMCB Organizing Committee is delighted to welcome you to present a speech in Section 410: Tissue Repair & Regeneration. Your prompt reply with a speech proposal will be highly appreciated. Your presence will make conference successful.

CMCB-2017 supporting by Shaanxi Society of Cell Biology is highlighted as Keynote Forum, 36 Parallel Sessions with 300+ Oral Speeches, Posters and Papers, and Diversified Social Events. Each day will include 10 concurrent focus sessions, each focus session featuring speakers who will present cutting-edge research on a wide range of topics. We sincerely welcome you to submit presentation abstract, short paper or preliminary speech title. Please visit the conference website to see the conference details.

If you have any question about the conference, please feel free to let me know.

Kind regards

Judy

Journal of Stem Cell Research & Therapeutics (JSRT)

Journal of Stem Cell Research & Therapeutics (JSRT)

Dear Dr. Anand S Srivastava,

Greetings from MedCrave Group!

Hope you are doing well.

We are pleased to inform you that Journal of Stem Cell Research & Therapeutics (JSRT) has successfully received ISSN from the U.S. ISSN CENTER with ISSN: 2475-5540.

We would like to thank you for your enormous contribution towards release of issues in time which supported our Journal in achieving so. Also all the peer reviewed articles published in MedCrave will be provided with DOI (Digital Object Identification) number from Cross Ref which will help locating & identifying the articles from anywhere in the world.

MedCrave Group values eminent scientists like you, and wishes to have your everlasting support.

Have a Great Day!

Regards
Melissa Hawkins

Make An Inquiry

We are here to help you

WordPress Video Lightbox